The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...

Researchers at The University of Texas Health Science Center at San Antonio have discovered a way to delay or even block ...

The FDA has approved an investigational device exemption (IDE) application for the start of a pilot study evaluating the Alpha diffusing alpha-emitters radiation therapy (DaRT) technology in patients ...

Ironically, the scientists found that the customary treatment for glioblastoma, ionizing radiation, can also cause tumors to recur, by generating senescent or aged cells that secrete molecules ...

Scientists at UT Health San Antonio have found a promising way to stop glioblastoma—the deadliest type of brain cancer—from ...

Research led by The University of Texas Health Science Center at San Antonio identifies a means of blocking recurrence of glioblastoma, the deadliest brain cancer. Ironically, the scientists found ...

Glioblastoma is a fast-growing glioma, a type of tumor that arises from glial cells, which protect nerve cells in the brain ...

Ironically, the scientists found that the customary treatment for glioblastoma, ionizing radiation, can also cause tumors to recur, by generating senescent or aged cells that secrete molecules that ...

The former lawmaker from Utah had undergone treatment for glioblastoma, a malignant brain tumor, and received immunotherapy ...